» Articles » PMID: 27646971

MDCT of Pelvic Inflammatory Disease: a Review of the Pathophysiology, Gamut of Imaging Findings, and Treatment

Overview
Journal Emerg Radiol
Date 2016 Sep 21
PMID 27646971
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Representing an ascending, sexually spread pyogenic infection of the female genital tract, pelvic inflammatory disease (PID) is a commonly encountered cause for emergency visits and hospitalizations among young and adult female patients. Though gynecologic evaluation and sonography constitute the mainstay of diagnosis, multidetector CT imaging of the abdomen and pelvis is not uncommonly performed, often as the initial imaging modality, due to the frequently vague and indeterminate clinical presentation. As such, knowledge and attenuation to the often subtle early imaging features of PID afford the radiologist a critical chance to direct and expedite appropriate pathways of patient care, minimizing the risk for secondary complications, including infertility, ectopic pregnancy, and enteric adhesions. In this paper, we will review the pathophysiology, clinical presentation, early and late imaging features of PID as well as potential secondary complications and treatment options. Additionally, we will discuss published data metrics on CT performance regarding sensitivity and specificity for diagnosis as well as potential imaging differential diagnostic considerations.

Citing Articles

Exploring the therapeutic effect of Pen Yan Kang Fu Decoction on SPID rats based on LIF/JAK2/STAT3 signaling pathway.

Ji X, Hu Q, Yang C, Huang L, Huang Y, Deng L 3 Biotech. 2024; 14(5):134.

PMID: 38665879 PMC: 11039587. DOI: 10.1007/s13205-024-03981-0.


Imaging findings in inflammatory disease of the genital organs.

Shibuki S, Saida T, Hoshiai S, Ishiguro T, Sakai M, Amano T Jpn J Radiol. 2024; 42(4):331-346.

PMID: 38165529 PMC: 10980613. DOI: 10.1007/s11604-023-01518-8.


Shipi Shugan Decoction Protected against Sequela of Pelvic Inflammatory Disease via Inhibiting SIRT1/NLRP3 Signaling Pathway in Pelvic Inflammatory Disease Rats.

Wang Y, Huang Y, Shi L, Huang L, Wen Y, Cao Y Evid Based Complement Alternat Med. 2022; 2022:6382205.

PMID: 36106027 PMC: 9467799. DOI: 10.1155/2022/6382205.


The effect of adjuvant treatment in chronic pelvic inflammation by Fukejing capsules and its influence on hemorheology and inflammatory factors.

Wang X, Shi W, Shi X, Lin H, Qian X Am J Transl Res. 2021; 13(4):3480-3486.

PMID: 34017525 PMC: 8129380.


Analysis of the etiologies of female infertility in Yunnan minority areas.

Zhang F, Feng Q, Yang L, Liu X, Su L, Wang C BMC Womens Health. 2021; 21(1):88.

PMID: 33648484 PMC: 7923498. DOI: 10.1186/s12905-021-01216-5.


References
1.
Jossens M, Eskenazi B, Schachter J, Sweet R . Risk factors for pelvic inflammatory disease. A case control study. Sex Transm Dis. 1996; 23(3):239-47. DOI: 10.1097/00007435-199605000-00014. View

2.
Reed S, Landers D, Sweet R . Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agents versus clindamycin-containing regimens. Am J Obstet Gynecol. 1991; 164(6 Pt 1):1556-61; discussion 1561-2. DOI: 10.1016/0002-9378(91)91436-z. View

3.
Kim J, Kim Y, Jeong W, Song S, Cho O . Perihepatitis with pelvic inflammatory disease (PID) on MDCT: characteristic findings and relevance to PID. Abdom Imaging. 2008; 34(6):737-42. DOI: 10.1007/s00261-008-9472-9. View

4.
Yudin M, Hillier S, Wiesenfeld H, Krohn M, Amortegui A, Sweet R . Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease. Am J Obstet Gynecol. 2003; 188(2):318-23. DOI: 10.1067/mob.2003.105. View

5.
Jung S, Kim Y, Park H, Jeon H, Jeong K . Acute pelvic inflammatory disease: diagnostic performance of CT. J Obstet Gynaecol Res. 2010; 37(3):228-35. DOI: 10.1111/j.1447-0756.2010.01380.x. View